Issue 1, 2013

Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity

Abstract

Tobramycin-based cationic amphiphiles differing in the chemical bond linking their hydrophobic and hydrophilic parts were synthesized and biologically evaluated. Several compounds demonstrated potent antimicrobial activities compared to the parent drug. One analogue exhibited a significant reduction in red blood cells hemolysis, demonstrating that it is possible to maintain the antimicrobial potency of these molecules while reducing their undesired hemolytic effect through chemical modifications.

Graphical abstract: Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity

Supplementary files

Article information

Article type
Concise Article
Submitted
21 Jun 2012
Accepted
20 Jul 2012
First published
13 Aug 2012

Med. Chem. Commun., 2013,4, 120-124

Design of membrane targeting tobramycin-based cationic amphiphiles with reduced hemolytic activity

I. M. Herzog, M. Feldman, A. Eldar-Boock, R. Satchi-Fainaro and M. Fridman, Med. Chem. Commun., 2013, 4, 120 DOI: 10.1039/C2MD20162C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements